Pulmonary 3 T MRI with ultrashort TEs: Influence of ultrashort echo time interval on pulmonary functional and clinical stage assessments of smokers

Journal of Magnetic Resonance Imaging

Volumn 39, Issue 4, 2014, Pages 988-997

  Ohno, Yoshiharu ^a   Nishio, Mizuho ^a   Koyama, Hisanobu ^a   Yoshikawa, Takeshi ^a   Matsumoto, Sumiaki ^a   Seki, Shinichiro ^a   Obara, Makoto ^b   Van Cauteren, Marc ^b   Takahashi, Masaya ^c   Sugimura, Kazuro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b PHILIPS HEALTHCARE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

COPD; CT; lung; magnetic resonance; pulmonary emphysema; ultrashort echo time

Indexed keywords

AGED; ARTICLE; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL ASSESSMENT; HUMAN; IMAGE ANALYSIS; LUNG FUNCTION TEST; LUNG PARENCHYMA; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAXATION TIME; SMOKING; ULTRASHORT ECHO TIME NUCLEAR MAGNETIC RESONANCE IMAGING;

COPD; CT; LUNG; MAGNETIC RESONANCE; PULMONARY EMPHYSEMA; ULTRASHORT ECHO TIME;

AGED; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG; MAGNETIC RESONANCE IMAGING; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; SENSITIVITY AND SPECIFICITY; SMOKING;

EID: 84897026481     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24232     Document Type: Article

References (37)

1. Curbing the epidemic: governments and the economics of tobacco control. World Bank Tob Control 1999; 8: 196-201.
2. The world health report 2003-shaping the future. Geneva, Switzerland: World Health Organization, 2003.
3. Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ,. Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? Eur Respir J 2009; 33: 468-480.
4. Thun MJ, Carter BD, Feskanich D, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med 2013; 368: 351-364.
5. Ezzati M, Lopez AD,. Estimates of global mortality attributable to smoking in 2000. Lancet 2003; 362: 847-852.
6. Murray CJ, Lopez AD,. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 1996; 274: 740-743.
7. Mishima M, Itoh H, Sakai H, et al. Optimized scanning conditions of high resolution CT in the follow-up of pulmonary emphysema. J Comput Assist Tomogr 1999; 23: 380-384.
8. Zaporozhan J, Ley S, Eberhardt R, et al. Paired inspiratory/expiratory volumetric thin-slice CT scan for emphysema analysis: comparison of different quantitative evaluations and pulmonary function test. Chest 2005; 128: 3212-3220.
9. Coxson HO, Rogers RM,. Quantitative computed tomography of chronic obstructive pulmonary disease. Acad Radiol 2005; 12: 457-1463.
10. Hoffman EA, Simon BA, McLennan G,. State of the art. A structural and functional assessment of the lung via multidetector-row computed tomography: phenotyping chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3: 519-532.
11. Alford SK, van Beek EJ, McLennan G, Hoffman EA,. Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers. Proc Natl Acad Sci U S A 2010; 107: 7485-7490.
12. Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPD Gene) study design. COPD 2010; 7: 32-43.
13. Fain SB, Panth SR, Evans MD, et al. Early emphysematous changes in asymptomatic smokers: detection with 3He MR imaging. Radiology 2006; 239: 875-883.
14. Diaz S, Casselbrant I, Piitulainen E, et al. Hyperpolarized 3He apparent diffusion coefficient MRI of the lung: reproducibility and volume dependency in healthy volunteers and patients with emphysema. J Magn Reson Imaging 2008; 27: 763-770.
15. van Beek EJ, Dahmen AM, Stavngaard T, et al. Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial. Eur Respir J 2009; 34: 1311-1321.
16. Kirby M, Svenningsen S, Owrangi A, et al. Hyperpolarized 3He and 129Xe MR imaging in healthy volunteers and patients with chronic obstructive pulmonary disease. Radiology 2012; 265: 600-610.
17. Ohno Y, Iwasawa T, Seo JB, et al. Oxygen-enhanced magnetic resonance imaging versus computed tomography: multicenter study for clinical stage classification of smoking-related chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177: 1095-1102.
18. Jang YM, Oh YM, Seo JB, et al. Quantitatively assessed dynamic contrast-enhanced magnetic resonance imaging in patients with chronic obstructive pulmonary disease: correlation of perfusion parameters with pulmonary function test and quantitative computed tomography. Invest Radiol 2008; 43: 403-410.
19. Ley-Zaporozhan J, van Beek EJ,. Imaging phenotypes of chronic obstructive pulmonary disease. J Magn Reson Imaging 2010; 32: 1340-1352.
20. Togao O, Tsuji R, Ohno Y, Dimitrov I, Takahashi M,. Ultrashort echo time (UTE) MRI of the lung: assessment of tissue density in the lung parenchyma. Magn Reson Med 2010; 64: 1491-1498.
21. Takahashi M, Togao O, Obara M, et al. Ultrashort echo time (UTE) MR imaging of the lung: comparison between normal and emphysematous lungs in mutant mice. J Magn Reson Imaging 2010; 32: 326-333.
22. Ohno Y, Koyama H, Yoshikawa T, et al. T2* measurements of 3-T MRI with ultrashort TEs: capabilities of pulmonary function assessment and clinical stage classification in smokers. AJR Am J Roentgenol 2011; 197: W279-W285.
23. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS,. GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 2001; 46: 798-825.
24. American Thoracic Society. Standardization of spirometry-1987 update. Am Rev Respir Dis 1987; 136: 285-1298.
25. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 202-1218.
26. American Thoracic Society. Single breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique. Statement of the American Thoracic Society. Am Rev Respir Dis 1987; 136: 1299-1307.
27. Hasegawa M, Nasuhara Y, Onodera Y, et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 1309-1315.
28. Matsuoka S, Kurihara Y, Yagihashi K, Hoshino M, Nakajima Y,. Airway dimensions at inspiratory and expiratory multisection CT in chronic obstructive pulmonary disease: correlation with airflow limitation. Radiology 2008; 248: 1042-1049.
29. Bland JM, Altman DG,. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
30. Bland JM, Altman DG,. Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol 2003; 22: 85-93.
31. Durney CH, Bertolina J, Alion DC, et al. Calculation and interpretation of inhomogeneous structures. J Magn Reson 1989; 85: 554-570.
32. Hatabu H, Alsop DC, Listerud J, Bonnet M, Gefter WB,. T2* and proton density measurement of normal human lung parenchyma using submillisecond echo time gradient echo magnetic resonance imaging. Eur J Radiol 1999; 29: 245-252.
33. Boss A, Schaefer S, Martirosian P, Claussen CD, Schick F, Schaefer JF,. Magnetic resonance imaging of lung tissue: influence of body positioning, breathing and oxygen inhalation on signal decay using multi-echo gradient-echo sequences. Invest Radiol 2008; 43: 433-438.
34. Olsson LE, Lindahl M, Onnervik PO, et al. Measurement of MR signal and T2* in lung to characterize a tight skin mouse model of emphysema using single-point imaging. J Magn Reson Imaging 2007; 25: 488-494.
35. Lederer DJ, Enright PL, Kawut SM, et al. Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. Am J Respir Crit Care Med 2009; 180: 407-414.
36. Wan ES, Hokanson JE, Murphy JR, et al.; COPD Gene Investigators. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPD Gene study. Am J Respir Crit Care Med 2011; 184: 57-63.
37. Kim V, Han MK, Vance GB, et al. COPD Gene Investigators. The chronic bronchitic phenotype of COPD: an analysis of the COPD Gene Study. Chest 2011; 140: 626-633.